LINKÖPING, Sweden and
SHELTON, CT, Dec. 2, 2019 /PRNewswire/ -- International
medical imaging IT and cybersecurity company Sectra (STO: SECT
B) and Leica Biosystems announce collaboration for an integrated
clinical pathology solution. The goal is to address the clinical
needs of enterprise level customers such as academic medical
centers, clinical research organizations and large hospital
networks. A 510(k) application for the combined solution has been
submitted to the U.S. Food & Drug Administration (FDA).
"Leveraging Leica Biosystems' existing 510(k) clearance for its
Aperio AT2 DX scanner, and extending it with the Sectra Digital
Pathology Solution for hospitals and health systems, enable us to
deliver a clinical solution to meet the needs of the truly
integrated digital hospitals of today and tomorrow," says Torbjörn
Kronander, Founder & CEO of Sectra. "This is an exciting and
important advancement for the clinical pathology industry and a
huge step forward in clinical usability."
The Sectra digital pathology software solution, a component of
the enterprise imaging offering, will facilitate streamlined image
access, review, and diagnosis, as well as deep integration with
leading pathology information systems and EMRs. Leica Biosystems
Aperio AT2 DX system is a high-throughput automated digital scanner
that delivers diagnostic-quality whole slide images with high
confidence. The integration of these two solid platforms will
enable clinical organizations to deliver a scalable, unified
solution for optimized patient care and financial
outcomes.
Leica Biosystems is committed to investing in the development of
Aperio Digital Pathology software, image analysis and hardware
solutions. Moreover, Leica Biosystems recognizes the need for a
wide variety of use cases and applications which simply cannot be
addressed by a single provider. Leica Biosystems' open platform
will enable customers to choose their preferred workflow
solutions.
"This is an important step towards improving patient care with
digital technology," says Colin
White, Global Vice President of Leica Biosystems Advanced
Staining & Imaging Business. "We look forward to working with
Sectra to offer streamlined digital pathology solutions for
clinical organizations."
The clinical use claims described for primary diagnosis have not
been cleared or approved by the U.S. FDA. Any future capabilities
will require FDA clearance before diagnostic use.
About Sectra Imaging IT Solutions
With more than 25 years of innovation and 1,800 installations,
Sectra is a leading global provider of imaging IT solutions that
support healthcare in achieving patient-centric care. Sectra offers
an enterprise imaging solution comprising PACS for imaging-intense
departments (radiology, pathology, cardiology, orthopedics), VNA,
and share and collaborate solutions. Read more about Sectra and why
Sectra PACS is "Best in KLAS" for a sixth consecutive year at
http://www.sectra.com/medical/
.
About Leica Biosystems
Leica Biosystems (LeicaBiosystems.com) is a cancer diagnostics
company and a global leader in workflow solutions, offering the
most comprehensive portfolio from biopsy to diagnosis. With unique
expertise, Leica Biosystems is dedicated to driving innovations
that connect people across radiology, pathology, surgery and
oncology. The mission of "Advancing Cancer Diagnostics, Improving
Lives" is at the heart of the corporate culture. The easy-to-use
and consistently reliable offerings help improve workflow
efficiency and diagnostic confidence. The company is headquartered
in Germany and operates in over
100 countries.
For further information, please contact:
Dr. Torbjörn
Kronander
CEO and President Sectra AB
+46(0)705-23-52-27
Marie Ekström Trägårdh
Executive Vice President Sectra AB and President Sectra Imaging IT
Solutions
+46(0)708-23-56-10
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/sectra/r/sectra-and-leica-biosystems-partner-to-pursue-fda-clearance-for-an-integrated-clinical-digital-patho,c2976118
The following files are available for download:
https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c2722160
|
Sectra's digital
pathology solution
|